(PharmaNewsWire.Com, January 11, 2017 ) Renal denervation is a catheter-based minimally-invasive ablation procedure that helps reduce systolic blood pressure in individuals with drug-resistant hypertension. Systolic blood pressure is the first recorded reading. Diastolic blood pressure measures the pressure in the blood vessels when the heart rests between beats. The renal denervation catheter is introduced through the femoral artery in the upper thigh. The physician then makes several lesions using radiofrequency or ultrasound along the sympathetic nerves. These nerves connect the brain, heart, blood vessels, and kidneys, and play a major role in the management of hypertension.
Publisher's analysts forecast the global renal denervation market to grow at a CAGR of 11.82% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-renal-denervation-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global renal denervation market for 2016-2020. To calculate the market size, Publisher considers the revenue generated from the sales of renal denervation devices as the demand for these devices is high.
The market is divided into the following segments based on geography: - Europe - ROW
Publisher's report, Global Renal Denervation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Boston Scientific - Medtronic - ReCor Medical - St. Jude Medical
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: